Sunday, May 11, 2025 5/11/2025

Recapitulation of the two-cell visual cycle in photoreceptors and its effects on retinoid flux and remedy of toxic retinoid species

Award Number: F31EY034027
ORGANIZATION: NATIONAL EYE INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Group Awards By:

View Award Description

Recapitulation of the two-cell visual cycle in photoreceptors and its effects on retinoid flux and remedy of toxic retinoid species - PROJECT SUMMARY/ ABSTRACT. Retinal degenerative (RD) diseases result in a progressive loss of vision, and have a devastating impact on a patient’s quality of life. Many genetic factors that nucleate these diseases are intricately linked to defects in the visual (retinoid) cycle. This cycle is necessary for regenerating the essential visual pigment 11-cis-retinal after it is photoisomerized to all-trans-retinal; errors in this multi-step recycling of all-trans-retinal back to 11-cis- retinal leads to the buildup of toxic retinoid photo-oxidation products that can kill photoreceptors and the supporting retinal pigment epithelium (RPE). Few therapeutic options exist for mitigating the damage that is caused by these photo-oxidation products, especially after cell death in the retina has started to affect quality of vision. Normally, the vertebrate visual cycle is distributed across two distinct cell types, the retinal pigment epithelium and the photoreceptors (i.e., rods and cones). In the functional visual cycle, 11-cis-retinal is initially bound to opsin proteins within the photoreceptors, where it is then isomerized to all-trans-retinal in the presence of light. This transformation initiates the phototransduction signaling cascade that travels through optic nerve to the brain, where the signals are integrated into a coherent visual field. The all-trans-retinal molecules are then shed by opsins and converted to all-trans-retinol by all-trans-retinal dehydrogenase. The all-trans-retinol is then transported from the photoreceptors to one of two “helper” cell types- RPE cells that support both rod and cone function, and Müller cells that solely support cones. Because RPE-linked visual cycle dysfunction has a greater impact on the retina as a whole, we’ve elected to focus on just the RPE-based visual cycle and not the cone- exclusive alternative visual cycle. When all-trans-retinol is transported from the photoreceptors to the RPE, the all-trans-retinol undergoes two key reactions; one catalyzed by lecithin-retinol acyltransferase (abbr. Lrat), and the other by retinal pigment epithelium-specific 65 kDa (abbr. Rpe65). Lrat catalyzes the coupling of all-trans retinol to fatty acids, forming stable retinyl ester intermediates. These retinyl esters are subsequently isomerized and hydrolyzed by Rpe65 to give 11-cis-retinol. 11-cis-retinol is then oxidized to 11-cis-retinal by 11-cis-retinol dehydrogenases and transported back to the photoreceptors for re-use. When the visual cycle is hindered, all-trans retinal can build up in the photoreceptors, leading to the formation of toxic photo-oxidation products that cause retinal degeneration. I intend to expand our knowledge of the visual cycle via engineered expression of Lrat and Rpe65 in the photoreceptors. In studying how manipulation of retinoid flux in the visual cycle controls the emergence and progression of RD, we can optimize therapeutic interventions that target the central drivers of retinal disease, while simultaneously reversing the toxic buildup of retinoids in chronic RD.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $43,796 )
2024	2024	UNIVERSITY OF CALIFORNIA IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Vision Research	000	3	5/3/2024	NON-COMPETING CONTINUATION	$43,796
														Subtotal = $43,796

Issue Date FY: 2023 ( Subtotal = $42,516 )
2023	2023	UNIVERSITY OF CALIFORNIA, IRVINE	160 ALDRICH HALL	IRVINE	CA	92697	ORANGE	USA	Vision Research	000	2	4/3/2023	NON-COMPETING CONTINUATION	$42,516
														Subtotal = $42,516

Issue Date FY: 2022 ( Subtotal = $41,574 )
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Vision Research	002	1	5/6/2022	NEW	$717
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Vision Research	003	1	5/27/2022	NEW	-$1
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Vision Research	000	1	3/25/2022	NEW	$40,858
2022	2022	UNIVERSITY OF CALIFORNIA, IRVINE	141 INNOVATION DR STE 250	IRVINE	CA	92617	ORANGE	USA	Vision Research	001	1	3/25/2022	NEW	$0
														Subtotal = $41,574

Grand Total All Awards = $127,886

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Recapitulation of the two-cell visual cycle in photoreceptors and its effects on retinoid flux and remedy of toxic retinoid species

Award Number: F31EY034027

ORGANIZATION: NATIONAL EYE INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer